| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.72 | 0.1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |